Şunu aradınız:: infants and toddlers (İngilizce - Maltaca)

infants and toddlers from the age of 4 weeks
trabi u tfal Żgħar minn età ta’ 4 ġimgħat

infants and toddlers 4 weeks to less than 2 years of age
tfal żgħar u trabi ta’ 4 ġimgħat jew inqas minn sentejn

immunogenicity in infants and children
immunoġeniċità fit-trabi u tfal

term newborn infants and infants:
trabi tat-twelid u tfal żgħar:

do not administer fluenz to infants and toddlers younger than 12 months.
tagħtix fluenz lil tfal żgħar u trabi li għandhom inqas minn 12-il xahar.

foods for infants and young children
ikel għat-trabi u għat-tfal żgħar

dose for infants and toddlers from 4 weeks of age and weighing at least 3 kg
doża għal trabi u tfal żgħar ta’ età iżgħar minn 4 ġimgħat u li jiżnu għallinqas 3 kg

in infants and toddlers aged 6 to 24 months, it is reduced to 3.1 hours
f’ tfal żgħar u trabi ta ’ bejn is- 6- 24 il- xahar, dan kien mnaqqas għal 3. 1sigħat.

in infants and toddlers aged 6 to 24 months, it is reduced to 3.1 hours.
f’ tfal żgħar u trabi ta ’ bejn is- 6 u l- 24 xahar, dan kien mnaqqas għal 3. 1 sigħat.

it is not recommended to administer fluenz to infants and toddlers 12-23 months of age.
mhux rakkomandat li tagħti fluenz lil tfal żgħar u trabi li jkollhom età ta’ 12-23 xahar.

unvaccinated infants and children ≥ 7 months of age
trabi u tfal mhux imlaqqma li għandhom ≥ 7 xhur

infants and children (1 month to 4 years)
trabi u tfal (xahar sa 4 snin)

studies in new-born infants or infants and toddlers under 2 years of age have not been conducted.
ma sarux studji fuq tfal li għadhom jitwieldu jew trabi u tfal żgħar li huma taħt is-sentejn.

in 16 member states, treatment with cetirizine is also recommended in infants and toddlers aged 1 to 2 years.
fis- 16- il stat membru, it- trattament b’ cetirizine huwa rrakkomandat ukoll fi trabi u tfal żgħar li għandhom bejn sena u sentejn.

fluenz is not indicated for use in infants and toddlers younger than 24 months (see section 4.4).
fluenz mhuwiex indikat għall-użu fi tfal żgħar u trabi li għandhom inqas minn 24 xahar (ara sezzjoni 4.4).

fluenz tetra is not indicated for use in infants and toddlers younger than 24 months (see section 4.2).
fluenz tetra mhuwiex indikat għall-użu fi tfal żgħar u trabi li għandhom inqas minn 24 xahar (ara sezzjoni 4.2).

fluenz should not be used in infants and toddlers below 24 months of age because of safety concerns (see section 4.4).
fluenz m’għandiex jintuża fit-tfal żgħar u trabi ta’ eta` ta’ inqas minn 24 xahar minħabba tħassib dwar sigurtà (ara sezzjoni 4.4).

in these 26 infants and toddlers, the frequency, type and severity of drug related adverse reactions through week 48 were comparable to those observed in adults.
f’dawn is-26 tarbija u tfal żgħar, il-frekwenza, it-tip u s-severità tar-reazzjonijiet avversi relatati mal- mediċina sa Ġimgħa 48 kienu komparabbli ma’ dawk osservati fl-adulti.

data in infants and toddlers 6-35 months of age suggest a slight decrease in reactogenicity after the second dose, with no increase in rates of fever.
dejta fit-trabi u tfal żgħar li kellhom 6-35 xahar tissuġġerixxi tnaqqis żgħir fir-reattoġeniċità wara t-tieni doża, mingħajr l-ebda żieda fir-rati ta’ deni.

in a clinical study, an increase in hospitalisations was observed in infants and toddlers younger than 12 months after vaccination (see section 4.8).
fi studju kliniku, kienet osservata żieda fir-rata ta’ tfal żgħar u trabi iżgħar minn 12-il xahar li kellhom jiddaħħlu l-isptar wara t-tilqima (ara sezzjoni 4.8).